A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

Oncologist - United States
doi 10.1634/theoncologist.2014-0424
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Unmet Needs in the Treatment of Metastatic Non-Small-Cell Lung Cancer

European Oncology and Haematology
OncologyHematology
2008English

Profile of Ramucirumab in the Treatment of Metastatic Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma

2013English

Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Network Meta-Analysis

Immunotherapy
OncologyAllergyImmunology
2019English

Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2011English

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

BMJ
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy